QuantaMatrix Past Earnings Performance

Past criteria checks 0/6

QuantaMatrix has been growing earnings at an average annual rate of 14.1%, while the Biotechs industry saw earnings growing at 3.8% annually. Revenues have been growing at an average rate of 27.7% per year.

Key information

14.1%

Earnings growth rate

39.6%

EPS growth rate

Biotechs Industry Growth	11.7%
Revenue growth rate	27.7%
Return on equity	-233.7%
Net Margin	-444.4%
Last Earnings Update	30 Sep 2024

Recent past performance updates

No updates

Recent updates

Health Check: How Prudently Does QuantaMatrix (KOSDAQ:317690) Use Debt?

Nov 26

Is QuantaMatrix (KOSDAQ:317690) Using Debt In A Risky Way?

Jul 19

What Type Of Shareholders Make Up QuantaMatrix Inc.'s (KOSDAQ:317690) Share Registry?

Mar 10

Revenue & Expenses Breakdown

How QuantaMatrix makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A317690 Revenue, expenses and earnings (KRW Millions)
Date	Revenue	Earnings	G+A Expenses	R&D Expenses
30 Sep 24	3,746	-16,648	12,317	4,766
30 Jun 24	3,605	-17,943	13,527	5,200
31 Mar 24	3,483	-20,221	14,376	5,361
31 Dec 23	3,118	-21,556	15,550	5,778
30 Sep 23	1,606	-20,469	13,875	6,067
30 Jun 23	1,460	-19,688	13,318	5,806
31 Mar 23	1,333	-19,537	13,431	5,608
31 Dec 22	1,286	-19,237	12,837	5,492
30 Sep 22	1,098	-20,083	13,464	5,308
30 Jun 22	901	-19,672	13,033	5,144
31 Mar 22	789	-19,057	12,267	5,077
31 Dec 21	550	-18,116	11,406	5,122
30 Sep 21	673	-16,594	10,788	4,572
30 Jun 21	665	-15,963	10,043	4,556
31 Mar 21	1,736	-15,073	9,183	4,717
31 Dec 20	1,689	-14,659	8,567	4,776
30 Sep 20	1,885	-15,569	8,841	5,488
30 Jun 20	1,834	-17,023	8,738	5,736
31 Mar 20	709	-40,791	8,467	5,638
31 Dec 19	811	-63,811	8,123	5,202
31 Dec 18	85	-16,009	6,111	4,050
31 Dec 17	47	-12,423	4,247	3,459

Quality Earnings: A317690 is currently unprofitable.

Growing Profit Margin: A317690 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A317690 is unprofitable, but has reduced losses over the past 5 years at a rate of 14.1% per year.

Accelerating Growth: Unable to compare A317690's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A317690 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (7.9%).

Return on Equity

High ROE: A317690 has a negative Return on Equity (-233.73%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/26 23:48
End of Day Share Price	2024/12/26 00:00
Earnings	2024/09/30
Annual Earnings	2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

QuantaMatrix Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution